Grab sources and key details here.
As mentioned above, EFSH has several potential breakout catalysts to familiarize yourself with right now. Here's what to know:
No. 1 EFSH Potential Catalyst - Volatility Will Need To Be On High Watch For This Low Float Idea
According to the Yahoo Finance website, EFSH has a tiny low float.
The website reports this profile to have approximately 2.82Mn shares in its float.
Why is that important? It's important on one crucial level. Volatility.
Could more positive 2023 company news help provide a near term spark?
No. 2 EFSH Potential Catalyst - Recent Revenue News Suggests A Little-Known Company On The Rise
Over the past several months, the company has dropped some impressive revenue growth news.
Check it out:
(7/10) - 1847 Projects Revenue of Approximately $20Mn for the Second Quarter of 2023 Representing a 54% Increase Over the Same Period in 2022
(5/15) - 1847 Reports 27.6% Increase in Revenue to $15.4Mn and Achieves Pro-fit-ability for Q1 2023
(3/31) - 1847 Reports 59.6% Increase in Revenue to $48.9Mn for Fiscal 2022
What potential revenue increase could be in store for EFSH for the next quarter?
No. 3 EFSH Potential Catalyst - Could A Healthy Reversal Be Nearing As Key Technicals Lean Oversold?
As of close Thursday, Barchart was reporting this profile to have several oversold leaning technicals.
These technicals could be signaling a healthy reversal could be approaching in the near term.
Here's the definition of a "reversal" from Investopedia:
"A reversal is a change in the price direction of an asset. A reversal can occur to the upside or downside. Following an uptrend, a reversal would be to the downside. Following a downtrend, a reversal would be to the upside. Reversals are based on overall price direction and are not typically based on one or two periods/bars on a chart."
Now, here are some key technicals (as of close Thursday) that could signal EFSH to be leaning oversold and on the verge of a potential reversal.
- 9-Day Relative Strength Index: 34.41%
- 14-Day Relative Strength Index: 34.90%
When these numbers drop down to the 30% range and lower, they can be viewed as being in oversold territory. While in this territory, they can paint the picture of a profile that is undervalued.
- 14-Day Raw Stochastic: 15.35%
- 14-Day Williams %R: 84.65%
As the Raw Stochastic nears the 10% range and lower and the Williams %R nears the 90% range or higher, these technical indicators may also be viewed as oversold and undervalued.
Keep an eye on these technicals closely.
No. 4 EFSH Potential Catalyst - A Significant Order Pushes Company's ICU Eyewear Subsidiary Into The Spotlight
1847 Subsidiary, ICU Eyewear, Secures Large Purchase Order from Major Super Market Chain in Florida for Personal Care Products
NEW YORK, NY / ACCESSWIRE / April 14, 2023 / 1847 Holdings LLC ("1847" or the "Company") (NYSE American:EFSH), a unique holding company that combines the attractive attributes of owning private, lower-middle market businesses with the liquidity and transparency of a publicly traded company, today announced that its subsidiary, ICU Eyewear Holdings Inc. ("ICU"), has secured a large purchase order for personal care products with a major supermarket chain based in Florida, valued at over $260k.
1847 acquired ICU, a leading designer of Over-the-Counter (OTC), non-prescription reading glasses, sunglasses, blue light blocking eyewear, sun readers and outdoor specialty sunglasses in February 2023. In 2020, ICU formed its ICU Personal Care brand to serve the needs of existing and new customers for Personal Protective Equipment (PPE) and related personal care categories.
Mr. Ellery W. Roberts, CEO of 1847, commented, "ICU has done business with this well-known supermarket chain for almost 16 months now, and we are pleased to add new product lines to the roster. Importantly, we are leveraging ICU's growing distribution network with key retailers, as well as its robust supply chain and design capability to gain economies of scale. This latest order is strong validation of our acquisition strategy."
"Our eyewear line has earned the title of #1 provider of OTC eyewear at Target, in addition to their exclusive provider of personal care products. Given our reputation for value and quality, we are experiencing strong sales momentum at additional retailers, as evidenced by this latest significant order," stated Robert Rheaume VP of Sales of ICU Eyewear.
Read the full article here.
No. 5 EFSH Potential Catalyst - Closed Acquisition Should Lead To Increased Revenue Growth In The Future
1847 Closes Acquisition of ICU Eyewear, a Leading Eyewear Designer with Revenue in Excess of $19.0Mn and $1.7Mn of Adjusted EBITDA in 2021
Completes Unsecured Debt Financing of Approx. $2.8Mn with Two Premier Institutional In-vest-ors to Accelerate Growth
NEW YORK, NY / ACCESSWIRE / February 13, 2023 / 1847 Holdings LLC ("1847" or the "Company") (NYSE American:EFSH), a unique holding company that combines the attractive attributes of owning private, lower-middle market businesses with the liquidity and transparency of a publicly traded company, today announced that it has completed the acquisition of ICU Eyewear Holdings Inc. ("ICU"), a leading designer of Over-the-Counter (OTC), non-prescription reading glasses, sunglasses, blue light blocking eyewear, sun readers and outdoor specialty sunglasses. ICU was advised on the transaction by Threadstone LP.
Total consideration for the acquisition was $4.5Mn, consisting of $4Mn in cash and unsecured subordinated promissory notes in the principal amount of $500k. Additional details on the transaction are available in the Company's Form 8-K, which will be filed with the Securities and Exchange Commission and available on the Company's website.
ICU was founded in 1956 and is headquartered in Hollister, California. ICU is a recognized leader in reading eyewear and sunglasses, as well as select health and personal care items. ICU has 10 brands and a comprehensive and innovative product offering of over 3,000 SKUs across the reading glass, sunglass, and health & personal care segments. ICU's customer base consists of a broad range of national, regional and specialty retailers comprising over 7,500 retail locations. ICU is the only OTC eyewear supplier in the U.S. to have meaningful penetration in all significant retail channels including grocery, specialty, office supply, pharmacy, and outdoor sports stores.
Mr. Ellery W. Roberts, CEO of 1847, commented, "We are pleased to close this transaction which is another example of our successful acquisition strategy, targeting accretive and cash flow positive companies. ICU has developed a highly profitable and sustainable business model, with solid fi-nan-cials, positive EBITDA and gross margin of approximately 40%. Our ability to acquire these businesses at attractive multiples, with minimum dilution to shareholders, has enabled us to offer shareholders a meaningful cash dividend. We look forward to working closely with ICU's management team to achieve meaningful top and bottom-line growth."
Read the full article here.
EFSH Recap - The Top Potential Breakout Catalysts To Know Right Now
No. 1 - Volatility Will Need To Be On High Watch For This Low Float Idea
No. 2 - Recent Revenue News Suggests A Little-Known Company On The Rise
No. 3 - Could A Healthy Reversal Be Nearing As Key Technicals Lean Oversold?
No. 4 - A Significant Order Pushes Company's ICU Eyewear Subsidiary Into The Spotlight
No. 5 - Closed Acquisition Should Lead To Increased Revenue Growth In The Future
Coverage is officially initiated on EFSH. When time allows, do this: